Muhlenkamp & CO Inc Bristol Myers Squibb CO Transaction History

Muhlenkamp & CO Inc

$310 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$47.98 - $54.4 $157,614 - $178,704	3,285 Added 2.49%	135,045 $7.32 Million
Q4 2023 Jan 08, 2024	BUY	$48.48 - $57.85 $98,317 - $117,319	2,028 Added 1.56%	131,760 $6.76 Million
Q3 2023 Dec 06, 2023	BUY	$57.89 - $64.73 $9,436 - $10,550	163 Added 0.13%	129,732 $7.53 Million
Q2 2023 Jul 14, 2023	BUY	$63.71 - $70.74 $39,436 - $43,788	619 Added 0.48%	129,569 $8.29 Million
Q4 2022 Jan 31, 2023	BUY	$68.48 - $81.09 $13,490 - $15,974	197 Added 0.15%	128,950 $9.28 Million
Q3 2022 Nov 01, 2022	BUY	$0.13 - $76.84 $155 - $91,977	1,197 Added 0.94%	128,753 $9.15 Million
Q2 2022 Jul 18, 2022	BUY	$72.62 - $79.98 $47,203 - $51,987	650 Added 0.51%	127,556 $9.82 Million
Q1 2022 Apr 01, 2022	BUY	$61.48 - $73.72 $56,500 - $67,748	919 Added 0.73%	126,906 $9.27 Million
Q4 2021 Mar 29, 2022	BUY	$53.63 - $62.52 $30,461 - $35,511	568 Added 0.45%	125,987 $7.86 Million
Q3 2021 Dec 10, 2021	SELL	$59.17 - $69.31 $12,070 - $14,139	-204 Reduced 0.16%	125,419 $7.42 Million
Q2 2021 Aug 18, 2021	BUY	$61.91 - $67.42 $12,629 - $13,753	204 Added 0.16%	125,623 $8.39 Million
Q1 2021 Aug 18, 2021	BUY	$59.34 - $66.74 $16,674 - $18,753	281 Added 0.22%	125,419 $8.65 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $52,716 - $59,737	913 Added 0.73%	125,138 $7.76 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $54,673 - $60,585	952 Added 0.77%	124,225 $7.49 Million
Q2 2020 Aug 20, 2020	BUY	$54.82 - $64.09 $2,741 - $3,204	50 Added 0.04%	123,273 $7.25 Million
Q4 2019 Feb 20, 2020	BUY	$49.21 - $64.19 $6.06 Million - $7.91 Million	123,223 New	123,223 $7.91 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $9.02 Million - $11.2 Million	-178,436 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $231,351 - $266,331	3,861 Added 2.21%	178,436 $0
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $155,484 - $169,517	-2,594 Reduced 1.46%	174,575 $10.7 Million
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $44,460 - $51,310	-805 Reduced 0.45%	177,169 $11.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	177,974	177,974 $9.92 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.33 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.46 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.58 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Muhlenkamp & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Muhlenkamp & CO Inc with notifications on news.

Account